Drug Trial Radar · NCT01887938
An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy
Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
May 23, 2013
Primary completion
Feb 13, 2026
Study completion Feb 13, 2026
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.
- First posted
- Jun 27, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 years, up to 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect long-term safety data in participants with metachromatic leukodystrophy (MLD) who are receiving HGT-1110 and have participated in Study HGT-MLD-070 (NCT01510028) through Week 40.
Conditions
- Metachromatic Leukodystrophy (MLD)
Interventions
HGT-1110Biological
Participants will receive IT injection of HGT-1110.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline to Follow-up (Week 628)
- Presence of Anti-HGT-1110 Antibodies in Cerebrospinal Fluid (CSF) and SerumTime frame: Baseline until end of the study (Week 624)
Locations
15 sites in 7 countries. Site status is shown where the registry gives one.
The Children's Hospital at Westmead
Westmead, Australia
Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil
Detska Interni Klinika, Lf Mu A Fn Brno
Brno, Czechia
Rigshospitalet
Copenhagen, Denmark
Hopital Femme Mere Enfant
Bron, France
Hopital Gui de Chauliac - CHRU de Montpellier
Montpellier, France
CHU de Nantes
Nantes, France
CHR Orleans - Hopital La Source
Orléans, France
Hôpital de Bicêtre
Le Kremlin-Bicêtre, Île-de-France Region, France
Klinikum Oldenburg
Oldenburg, Germany
Marien-Hospital Wesel gGmbh
Wesel, Germany
Center for Pediatric Clinical Studies (CPCS)
Tübingen, Baden-Wurttemberg, Germany
Kitakyushu Municipal Yahata Hospital
Fukuoka, Japan
Kurashiki Central Hospital
Okayama Prefecture, Japan
Osaka University Hospital
Osaka, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.